About Pulmicort Respules®(budesonide inhalation suspension)
PULMICORT RESPULES is a medication delivered to children by a nebulizer, making the delivery more consistent. It is the first and only inhaled nebulized corticosteroid approved for children with asthma 12 months to 4 years of age.
PULMICORT RESPULES is indicated for children aged 12 months to 8 years.
PULMICORT RESPULES is a preventive type medicine. PULMICORT RESPULES is not a quick-relief medicine (bronchodilator) and should NOT be used to treat an acute asthma attack.
In clinical studies, the side effects experienced with PULMICORT RESPULES and how often they happened were similar to what was experienced with a non-medicated mist (placebo). These side effects included respiratory infection, runny nose, coughing, earache, viral infection, stomachache, oral thrush and nosebleeds. If a child is exposed to chicken pox or measles, consult your child's health care professional. If a child is switching to PULMICORT RESPULES from an oral (syrup or pill) corticosteroid, carefully follow the health care professional's instructions. This will help your child avoid health risks that may be linked with stopping the use of oral corticosteroids.
For more information on the symptoms and triggers of asthma, as well as potential treatment options, parents can visit www.everydaykidz.com.
About Childhood Asthma
Approximately 6.3 million children under 18 years of age have asthma, which makes it the leading serious chronic illness among children.4 In the year 2000, asthma resulted in 728,000 ED visits and 214,000 hospitalizations in patients under age 18,4 a
'"/>
Contact: Heather Law
heather.law@astrazeneca.com
302-886-1652
Burson-Marsteller
24-May-2005